Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
PCSAProcessa Pharmaceuticals, Inc.
| Figure | PCSAProcessa Pharmaceuticals, Inc.FY2022 · Dec |
|---|---|
| Revenue | $0.00 |
| Revenue, yoy | — |
| Net income | $13.56M |
| Net income, yoy | −14.5% |
| Net margin | — |
| Free cash flow | $11.25M |
| FCF margin | — |
| EPS, diluted | $10.36 |
Add another company.
Annual · FY2014–FY2022 · USD
From SEC EDGARSame fiscal periods, as filed